J9311 Injection rituximab, hyaluronidase
Also known as: rituximab hyaluronidase, Rituxan subcutaneous
Injection of rituximab combined with hyaluronidase, an anti-CD20 monoclonal antibody with enhanced subcutaneous delivery. B-cell depleting agent.
In Plain Language
lymphoma injection; B-cell cancer treatment
Clinical Context
Subcutaneous formulation of rituximab for chronic lymphocytic leukemia, follicular lymphoma, and diffuse large B-cell lymphoma.
RVU Information
CPT J9311 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J9311?
CPT J9311 (Injection rituximab, hyaluronidase) is a J Codes (Drugs) code. Injection of rituximab combined with hyaluronidase, an anti-CD20 monoclonal antibody with enhanced subcutaneous delivery. B-cell depleting agent.
How is J9311 administered?
CPT J9311 is administered by a healthcare provider, typically via injection or infusion. Subcutaneous formulation of rituximab for chronic lymphocytic leukemia, follicular lymphoma, and diffuse large B-cell lymphoma. It is used by Oncology, Hematology, Internal Medicine.
When is CPT J9311 used?
Subcutaneous formulation of rituximab for chronic lymphocytic leukemia, follicular lymphoma, and diffuse large B-cell lymphoma.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.